Recalls / Active ingredient / Everolimus
Everolimus
5 FDA drug recalls involving the active ingredient “Everolimus”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-10-10 | Class III | Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Man | Endo USA, Inc. |
| 2025-10-10 | Class III | Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Ma | Endo USA, Inc. |
| 2025-10-10 | Class III | Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manuf | Endo USA, Inc. |
| 2025-10-10 | Class III | Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Man | Endo USA, Inc. |
| 2025-09-05 | Class III | Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manuf | Endo USA, Inc. |